Skip to main content

stock

VVOS · Vivos Therapeutics, Inc.

What Vivos Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live VVOS price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on VVOS.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
20,118,023 as of 2026-08-13 (XBRL frame )

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
61.9%
Operating
-107.9%
Net
-121.8%

Returns

ROE
—
ROA
-105.4%

Health

Current ratio
0.2x
Debt/equity
—

Deep value

NCAV
-$23.92M
NCAV per share
-$1.19
Price/NCAV
Locked
NNWC
-$25.28M
NNWC per share
-$1.26
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$5.15M$2.95M-$4.83M-$5.48M
10-Q filed 2026-08-14
2026-03-31$5.14M$3.06M-$6.62M-$7.68M
10-Q filed 2026-05-20
2025-12-31$3.82M$2.99M-$6.38M-$6.89M
10-K filed 2026-04-15
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$6.78M$3.94M-$4.73M-$5.40M
10-Q filed 2025-11-19
2025-06-30$3.82M$2.11M-$4.87M-$5.01M
10-Q filed 2026-08-14
2025-03-31$3.02M$1.51M-$3.92M-$3.86M
10-Q filed 2026-05-20
2024-12-31$3.70M$2.10M-$2.81M-$2.83M
10-K filed 2026-04-15
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$3.86M$2.33M-$2.65M-$2.62M
10-Q filed 2025-11-19
Assets
$24.14M
Equity
-$3.81M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$17.44M-$19.89M-$21.17M-$17.60M
2024-12-31$15.03M-$11.17M-$11.14M-$13.26M
2023-12-31$13.80M-$17.30M-$13.58M-$12.75M
2022-12-31$16.02M-$25.03M-$23.84M-$20.51M
2021-12-31$16.89M-$20.38M-$20.29M-$18.13M
2020-12-31$13.07M-$12.04M-$12.06M-$5.80M
2019-12-31$11.39M-$10.58M-$10.75M-$5.52M

Company filings

since Wed Apr 29 · 3 offering filings in 12 months · since Fri Oct 24

events

  • Auditor change

    Auditor change
    Sep 308-K
  • Material agreement, Unregistered share sale

    Material agreementUnregistered share sale
    Sep 88-K/A
  • Material agreement, Unregistered share sale

    Material agreementUnregistered share sale
    Sep 48-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Aug 218-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Aug 118-K
  • Material agreement, Executive or director change

    Material agreementExecutive or director change
    Aug 38-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named VVOS, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about VVOS.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about VVOS.

nakagai

Signals on VVOS come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the VVOS board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Vivos Therapeutics, Inc. (VVOS): SEC filings, financials and insider trades · Nakagai